Nirupama Putcha1, Ciprian Crainiceanu1, Gina Norato1, Jonathan Samet2, Stuart F Quan3,4, Daniel J Gottlieb4,5, Susan Redline4,6, Naresh M Punjabi1. 1. 1 Johns Hopkins University, Baltimore, Maryland. 2. 2 University of Southern California, Los Angeles, California. 3. 3 University of Arizona, Tucson, Arizona. 4. 4 Brigham and Women's Hospital and. 5. 5 VA Boston Healthcare System, Boston, Massachusetts. 6. 6 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and.
Abstract
RATIONALE: Whether sleep-disordered breathing (SDB) severity and diminished lung function act synergistically to heighten the risk of adverse health outcomes remains a topic of significant debate. OBJECTIVES: The current study sought to determine whether the association between lower lung function and mortality would be stronger in those with increasing severity of SDB in a community-based cohort of middle-aged and older adults. METHODS: Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of the Sleep Heart Health Study. Proportional hazards models were used to calculate risk for all-cause mortality, with FEV1 and apnea-hypopnea index (AHI) as the primary exposure indicators along with several potential confounders. MEASUREMENTS AND MAIN RESULTS: All-cause mortality rate was 26.9 per 1,000 person-years in those with SDB (AHI ≥5 events/h) and 18.2 per 1,000 person-years in those without (AHI <5 events/h). For every 200-ml decrease in FEV1, all-cause mortality increased by 11.0% in those without SDB (hazard ratio, 1.11; 95% confidence interval, 1.08-1.13). In contrast, for every 200-ml decrease in FEV1, all-cause mortality increased by only 6.0% in participants with SDB (hazard ratio, 1.06; 95% confidence interval, 1.04-1.09). Additionally, the incremental influence of lung function on all-cause mortality was less with increasing severity of SDB (P value for interaction between AHI and FEV1, 0.004). CONCLUSIONS: Lung function was associated with risk for all-cause mortality. The incremental contribution of lung function to mortality diminishes with increasing severity of SDB.
RATIONALE: Whether sleep-disordered breathing (SDB) severity and diminished lung function act synergistically to heighten the risk of adverse health outcomes remains a topic of significant debate. OBJECTIVES: The current study sought to determine whether the association between lower lung function and mortality would be stronger in those with increasing severity of SDB in a community-based cohort of middle-aged and older adults. METHODS: Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of the Sleep Heart Health Study. Proportional hazards models were used to calculate risk for all-cause mortality, with FEV1 and apnea-hypopnea index (AHI) as the primary exposure indicators along with several potential confounders. MEASUREMENTS AND MAIN RESULTS: All-cause mortality rate was 26.9 per 1,000 person-years in those with SDB (AHI ≥5 events/h) and 18.2 per 1,000 person-years in those without (AHI <5 events/h). For every 200-ml decrease in FEV1, all-cause mortality increased by 11.0% in those without SDB (hazard ratio, 1.11; 95% confidence interval, 1.08-1.13). In contrast, for every 200-ml decrease in FEV1, all-cause mortality increased by only 6.0% in participants with SDB (hazard ratio, 1.06; 95% confidence interval, 1.04-1.09). Additionally, the incremental influence of lung function on all-cause mortality was less with increasing severity of SDB (P value for interaction between AHI and FEV1, 0.004). CONCLUSIONS: Lung function was associated with risk for all-cause mortality. The incremental contribution of lung function to mortality diminishes with increasing severity of SDB.
Authors: G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew Journal: J Epidemiol Community Health Date: 1999-04 Impact factor: 3.710
Authors: Jose M Marin; Joan B Soriano; Santiago J Carrizo; Ana Boldova; Bartolome R Celli Journal: Am J Respir Crit Care Med Date: 2010-04-08 Impact factor: 21.405
Authors: Milo A Puhan; Judith Garcia-Aymerich; Martin Frey; Gerben ter Riet; Josep M Antó; Alvar G Agustí; Federico P Gómez; Roberto Rodríguez-Roisín; Karel G M Moons; Alphons G Kessels; Ulrike Held Journal: Lancet Date: 2009-08-29 Impact factor: 79.321
Authors: Nancy H Stewart; Mollie Brittan; Maureen McElligott; Michael O Summers; Kaeli Samson; Valerie G Press Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-07-14
Authors: Ali Azarbarzin; Scott A Sands; Katie L Stone; Luigi Taranto-Montemurro; Ludovico Messineo; Philip I Terrill; Sonia Ancoli-Israel; Kristine Ensrud; Shaun Purcell; David P White; Susan Redline; Andrew Wellman Journal: Eur Heart J Date: 2019-04-07 Impact factor: 29.983